核酸増幅検査の市場規模、シェア、動向分析レポート：タイプ別、用途別、最終用途別、地域別、セグメント別予測、2023年～2030年

核酸増幅検査市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の核酸増幅検査市場規模は、2023年から2030年にかけて12.2％のCAGRを記録し、2030年には192億米ドルに達すると予測されています。

慢性疾患や感染症の早期発見に関する意識の高まりや、PCR技術の新たな技術的進歩が、市場成長を大きく促進すると予想される要因です。さらに、インフルエンザ、肝炎、性感染症などの感染症の世界の流行増加は、核酸増幅検査の需要を増加させ、市場成長にプラスの影響を与えると予想されます。

核酸増幅検査は、がんのような生命を脅かす病態を含む様々な病態の診断に応用できるため、近年多額の投資が行われています。例えば、セファイド社のGene Xpert技術の開発には、米国国立衛生研究所からの5,600万米ドル以上の助成金と、その他の米国政府部門からの約7,300万米ドルを含む、総額2億5,200万米ドル以上の公的投資が行われました。

さらに、核酸増幅検査の高い効率性と正確性により、培養ベースの同定などの従来の診断オプションよりもこの技術が好まれるようになっています。これらの特性が核酸増幅検査技術の成長を後押ししています。

COVID-19は、SARS-CoV-2ウイルスの検出のために、核酸増幅検査を含む迅速で正確な検査法に対する需要を高めています。この市場に関わる主な企業は、迅速かつポイント・オブ・ケア検査に対する高い需要を満たすため、等温核酸増幅技術に基づく検査などの新製品を開発してきました。

例えば、2020年3月、アボット・ラボラトリーズは、5分以内に陽性、13分以内に陰性の結果を出すことができるAbbott ID NOW COVID-19検査の緊急使用承認（EUA）を取得しました。パンデミックに後押しされたこうした戦略的イニシアチブは、近い将来の市場成長を後押しすると予想されます。

核酸増幅検査市場レポートハイライト

• ポリメラーゼ連鎖反応（PCR）検査は、高精度と多重化機能により幅広い病原体の検出が可能な検査タイプであるため、2022年には66.7%の最大シェアを占めました。
• アプリケーション別では、感染症が2022年に46.4%の最大シェアを占めました。感染症の世界の流行の高まりと、核酸増幅技術によって提供される効率的な検査の選択肢が、この分野を牽引しています。
• 北米は、2022年に37.1％の最大シェアを占めました。この地域には、確立されたヘルスケア部門とAbbott Laboratories;Illumina, Inc;Bio-Rad Laboratories, Incなどの主要プレーヤーが存在するためです。
• 中央検査室および標準検査室の最終用途セグメントは、ヘルスケア投資の増加と早期疾患診断のための核酸増幅検査の採用増加により、2022年の市場シェア41.9%で市場を独占しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 核酸増幅検査市場の変数、動向および範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 普及と成長の見通しマッピング
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因分析
• 核酸増幅検査市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 核酸増幅検査：タイプ別推定・動向分析

• 核酸増幅検査市場：重要なポイント
• 核酸増幅検査市場：動向と市場シェア分析、2022年および2030年
• ポリメラーゼ連鎖反応（PCR）検査
• 等温核酸増幅技術（INAAT）テスト
• リガーゼ連鎖反応（LCR）テスト

第5章 核酸増幅検査：用途別推定・動向分析

• 核酸増幅検査市場：重要なポイント
• 核酸増幅検査市場：動向と市場シェア分析、2022年および2030年
• 感染症検査
• オンコロジー検査
• 遺伝的およびミトコンドリア病検査

第6章 核酸増幅試験：最終用途別推定・動向分析

• 核酸増幅検査市場：重要なポイント
• 核酸増幅検査市場：動向と市場シェア分析、2022年および2030年
• 病院
• 中央およびリファレンスラボ
• その他

第7章 核酸増幅検査市場：地域別推定・動向分析

• 地域別の見通し
• 地域別の核酸増幅検査市場：重要なポイント
• 北米
• 欧州
• アジア太平洋地域
• ラテンアメリカ
• 中東・アフリカ

第8章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 市場参入企業の分類
  • F. Hoffmann-La Roche Ltd
  • Becton, Dickinson and Company
  • Danaher Corporation
  • Abbott Laboratories
  • Illumina, Inc.
  • Siemens Healthineers
  • bioMerieux SA
  • Novartis AG
  • Bio-Rad Laboratories, Inc.
  • Seegene Inc.

List of Tables

• Table 1 List of Abbreviations
• Table 2 North America nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
• Table 3 North America nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
• Table 4 North America nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
• Table 5 North America nucleic acid amplification testing market, by region, 2018 - 2030 (USD Million)
• Table 6 U.S. nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
• Table 7 U.S. nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
• Table 8 U.S. nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
• Table 9 Canada nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
• Table 10 Canada nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
• Table 11 Canada nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
• Table 12 Europe nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
• Table 13 Europe nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
• Table 14 Europe nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
• Table 15 Europe nucleic acid amplification testing market, by region, 2018 - 2030 (USD Million)
• Table 16 Germany nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
• Table 17 Germany nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
• Table 18 Germany nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
• Table 19 UK nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
• Table 20 UK nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
• Table 21 UK nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
• Table 22 France nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
• Table 23 France nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
• Table 24 France nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
• Table 25 Italy nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
• Table 26 Italy nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
• Table 27 Italy nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
• Table 28 Spain nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
• Table 29 Spain nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
• Table 30 Spain nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
• Table 31 Denmark nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
• Table 32 Denmark nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
• Table 33 Denmark nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
• Table 34 Sweden nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
• Table 35 Sweden nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
• Table 36 Sweden nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
• Table 37 Norway nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
• Table 38 Norway nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
• Table 39 Norway nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
• Table 40 Asia Pacific nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
• Table 41 Asia Pacific nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
• Table 42 Asia Pacific nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
• Table 43 Asia Pacific nucleic acid amplification testing market, by region, 2018 - 2030 (USD Million)
• Table 44 Japan nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
• Table 45 Japan nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
• Table 46 Japan nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
• Table 47 China nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
• Table 48 China nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
• Table 49 China nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
• Table 50 India nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
• Table 51 India nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
• Table 52 India nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
• Table 53 Australia nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
• Table 54 Australia nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
• Table 55 Australia nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
• Table 56 Thailand nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
• Table 57 Thailand nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
• Table 58 Thailand nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
• Table 59 South Korea nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
• Table 60 South Korea nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
• Table 61 South Korea nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
• Table 62 Latin America nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
• Table 63 Latin America nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
• Table 64 Latin America nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
• Table 65 Latin America nucleic acid amplification testing market, by region, 2018 - 2030 (USD Million)
• Table 66 Brazil nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
• Table 67 Brazil nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
• Table 68 Brazil nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
• Table 69 Mexico nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
• Table 70 Mexico nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
• Table 71 Mexico nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
• Table 72 Argentina nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
• Table 73 Argentina nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
• Table 74 Argentina nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
• Table 75 Middle East and Africa nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
• Table 76 Middle East and Africa nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
• Table 77 Middle East and Africa nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
• Table 78 Middle East and Africa nucleic acid amplification testing market, by region, 2018 - 2030 (USD Million)
• Table 79 South Africa nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
• Table 80 South Africa nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
• Table 81 South Africa nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
• Table 82 Saudi Arabia nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
• Table 83 Saudi Arabia nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
• Table 84 Saudi Arabia nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
• Table 85 UAE nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
• Table 86 UAE nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
• Table 87 UAE nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
• Table 88 Kuwait nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
• Table 89 Kuwait nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
• Table 90 Kuwait nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 Nucleic acid amplification testing: Market outlook
• Fig. 9 Nucleic acid amplification testing: Competitive insights
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook
• Fig. 12 Penetration and growth prospect mapping
• Fig. 13 Industry value chain analysis
• Fig. 14 Nucleic acid amplification testing market driver impact
• Fig. 15 Nucleic acid amplification testing market restraint impact
• Fig. 16 Nucleic acid amplification testing market strategic initiatives analysis
• Fig. 17 Nucleic acid amplification testing market: Type movement analysis
• Fig. 18 Nucleic acid amplification testing market: Type outlook and key takeaways
• Fig. 19 Polymerase chain reaction (PCR) tests market estimates and forecasts, 2018 - 2030
• Fig. 20 Isothermal nucleic acid amplification technology (INAAT) tests market estimates and forecasts, 2018 - 2030
• Fig. 21 Ligase chain reaction (LCR) tests market estimates and forecasts, 2018 - 2030
• Fig. 22 Nucleic acid amplification testing market: Application movement analysis
• Fig. 23 Nucleic acid amplification testing market: Application outlook and key takeaways
• Fig. 24 Infectious disease testing market estimates and forecasts, 2018 - 2030
• Fig. 25 Covid-19 testing market estimates and forecasts, 2018 - 2030
• Fig. 26 Mosquito borne disease testing market estimates and forecasts, 2018 - 2030
• Fig. 27 Influenza testing market estimates and forecasts, 2018 - 2030
• Fig. 28 Sexually transmitted infection testing market estimates and forecasts, 2018 - 2030
• Fig. 29 Hepatitis testing market estimates and forecasts, 2018 - 2030
• Fig. 30 Tuberculosis testing market estimates and forecasts, 2018 - 2030
• Fig. 31 Others testing market estimates and forecasts, 2018 - 2030
• Fig. 32 Oncology testing market estimates and forecasts, 2018 - 2030
• Fig. 33 Genetic & mitochondrial disease testing market estimates and forecasts, 2018 - 2030
• Fig. 34 Others testing market estimates and forecasts, 2018 - 2030
• Fig. 35 Nucleic acid amplification testing market: End-use movement analysis
• Fig. 36 Nucleic acid amplification testing market: End-use outlook and key takeaways
• Fig. 37 Hospitals market estimates and forecasts, 2018 - 2030
• Fig. 38 Central and reference laboratories market estimates and forecasts, 2018 - 2030
• Fig. 39 Others market estimates and forecasts, 2018 - 2030
• Fig. 40 Global nucleic acid amplification testing market: Regional movement analysis
• Fig. 41 Global nucleic acid amplification testing market: Regional outlook and key takeaways
• Fig. 42 North America market estimates and forecasts, 2018 - 2030
• Fig. 43 U.S. market estimates and forecasts, 2018 - 2030
• Fig. 44 Canada market estimates and forecasts, 2018 - 2030
• Fig. 45 Europe market estimates and forecasts, 2018 - 2030
• Fig. 46 UK market estimates and forecasts, 2018 - 2030
• Fig. 47 Germany market estimates and forecasts, 2018 - 2030
• Fig. 48 France market estimates and forecasts, 2018 - 2030
• Fig. 49 Italy market estimates and forecasts, 2018 - 2030
• Fig. 50 Spain market estimates and forecasts, 2018 - 2030
• Fig. 51 Denmark market estimates and forecasts, 2018 - 2030
• Fig. 52 Sweden market estimates and forecasts, 2018 - 2030
• Fig. 53 Norway market estimates and forecasts, 2018 - 2030
• Fig. 54 Asia Pacific market estimates and forecasts, 2018 - 2030
• Fig. 55 Japan market estimates and forecasts, 2018 - 2030
• Fig. 56 China market estimates and forecasts, 2018 - 2030
• Fig. 57 India market estimates and forecasts, 2018 - 2030
• Fig. 58 Australia market estimates and forecasts, 2018 - 2030
• Fig. 59 Thailand market estimates and forecasts, 2018 - 2030
• Fig. 60 South Korea market estimates and forecasts, 2018 - 2030
• Fig. 61 Latin America market estimates and forecasts, 2018 - 2030
• Fig. 62 Brazil market estimates and forecasts, 2018 - 2030
• Fig. 63 Mexico market estimates and forecasts, 2018 - 2030
• Fig. 64 Argentina market estimates and forecasts, 2018 - 2030
• Fig. 65 Middle East and Africa. market estimates and forecasts, 2018 - 2030
• Fig. 66 South Africa market estimates and forecasts, 2018 - 2030
• Fig. 67 Saudi Arabia market estimates and forecasts, 2018 - 2030
• Fig. 68 UAE market estimates and forecasts, 2018 - 2030
• Fig. 69 Kuwait market estimates and forecasts, 2018 - 2030

Nucleic Acid Amplification Testing Market Growth & Trends:

The global nucleic acid amplification testing market size is expected to reach USD 19.2 billion by 2030, registering a CAGR of 12.2% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Rising awareness regarding early detection of chronic and infectious diseases, and emerging technological advancements in PCR technology are the factors expected to significantly drive the market growth. In addition, the global rise in the prevalence of infectious diseases such as influenza, hepatitis, and sexually transmitted infections is anticipated to increase the demand for nucleic acid amplification testing and positively affect market growth.

Nucleic acid amplification testing has witnessed a high amount of investment in recent years due to its applicability to diagnose a variety of disease conditions, including life-threatening conditions such as cancer. For instance, the development of Cepheid's Gene Xpert technology involved a total public investment of over USD 252.0 million, including grants of more than USD 56.0 million from the National Institutes of Health, and around USD 73.0 million from other U.S. government departments.

Moreover, the high efficiency and accuracy of nucleic acid amplification testing have led to an increasing preference for the technique over traditional diagnostic options, such as culture-based identification. These attributes are boosting the growth of nucleic acid amplification testing technologies.

COVID-19 has increased demand for rapid and accurate testing methods, including nucleic acid amplification testing, for the detection of the SARS-CoV-2 virus. Key players involved in the market have developed new product offerings, such as isothermal nucleic acid amplification technology-based tests, to meet the high demand for rapid and point-of-care testing.

For instance, in March 2020, Abbott Laboratories received Emergency Use Authorization (EUA) for its Abbott ID NOW COVID-19 test which can deliver positive results within five minutes and negative results within 13 minutes. Such strategic initiatives fueled by the pandemic are expected to boost market growth in the near future.

Nucleic Acid Amplification Testing Market Report Highlights:

• Polymerase Chain Reaction (PCR) tests held the largest share of 66.7% in 2022 as the testing type allows for the high accuracy and multiplexing capabilities for the detection of a broad range of pathogens
• By application, infectious diseases accounted for the largest share of 46.4% in 2022. The rising prevalence of the infectious disease globally and efficient testing alternatives offered by nucleic acid amplification techniques are driving the segment
• North America held the largest share of 37.1% in 2022, due to the presence of an established healthcare sector and key players such as Abbott Laboratories; Illumina, Inc.; Bio-Rad Laboratories, Inc., and others in the region
• Central and reference laboratories end-use segment dominated the market in 2022 with a market share of 41.9% in 2022 due to the increasing healthcare investments and rising adoption of nucleic acid amplification tests for early disease diagnosis

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Type
  • 1.1.2. Application
  • 1.1.3. End-use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Application outlook
  • 2.2.3. End-use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Nucleic Acid Amplification Testing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
  • 3.3.2. Market Restraint Analysis
• 3.4. Nucleic Acid Amplification Testing Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Technological landscape
    • 3.4.2.3. Economic Landscape

Chapter 4. Nucleic Acid Amplification Testing: Type Estimates & Trend Analysis

• 4.1. Nucleic Acid Amplification Testing Market: Key Takeaways
• 4.2. Nucleic Acid Amplification Testing Market: Movement & Market Share Analysis, 2022 & 2030
• 4.3. Polymerase Chain Reaction (PCR) Tests
  • 4.3.1. Polymerase chain reaction (PCR) tests market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.4. Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
  • 4.4.1. Isothermal nucleic acid amplification technology (INAAT) tests market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.5. Ligase Chain Reaction (LCR) Tests
  • 4.5.1. Ligase Chain Reaction (LCR) Tests market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Nucleic Acid Amplification Testing: Application Estimates & Trend Analysis

• 5.1. Nucleic Acid Amplification Testing Market: Key Takeaways
• 5.2. Nucleic Acid Amplification Testing Market: Movement & Market Share Analysis, 2022 & 2030
• 5.3. Infectious Disease Testing
  • 5.3.1. Infectious disease testing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.3.2. Covid-19 Testing
    • 5.3.2.1. Covid-19 testing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.3.3. Mosquito Borne Disease Testing
    • 5.3.3.1. Mosquito borne disease testing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.3.4. Influenza Testing
    • 5.3.4.1. Influenza testing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.3.5. Sexually Transmitted Infectious Testing
    • 5.3.5.1. Sexually transmitted infectious testing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.3.6. Hepatitis Testing
    • 5.3.6.1. Hepatitis testing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.3.7. Tuberculosis Testing
    • 5.3.7.1. Tuberculosis testing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.3.8. Others
    • 5.3.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.4. Oncology Testing
  • 5.4.1. Oncology testing market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.5. Genetic & Mitochondrial Disease Testing
  • 5.5.1. Genetic & mitochondrial disease testing market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Nucleic Acid Amplification Testing: End Use Estimates & Trend Analysis

• 6.1. Nucleic Acid Amplification Testing Market: Key Takeaways
• 6.2. Nucleic Acid Amplification Testing Market: Movement & Market Share Analysis, 2022 & 2030
• 6.3. Hospitals
  • 6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.4. Central and Reference Laboratories
  • 6.4.1. Central and reference Laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.5. Others
  • 6.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Nucleic Acid Amplification Testing Market: Regional Estimates & Trend Analysis

• 7.1. Regional Outlook
• 7.2. Nucleic Acid Amplification Testing Market by Region: Key Takeaways
• 7.3. North America
  • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.3. France
    • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.6. Denmark
    • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.8. Norway
    • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.2. China
    • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.3. India
    • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.4. Australia
    • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.5. Thailand
    • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.6. South Korea
    • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6.2. Mexico
    • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Market Participant Categorization
  • 8.2.1. F. Hoffmann-La Roche Ltd
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. Becton, Dickinson and Company
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Danaher Corporation
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Abbott Laboratories
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Illumina, Inc.
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Siemens Healthineers
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. bioMerieux SA
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Novartis AG
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Bio-Rad Laboratories, Inc.
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Seegene Inc.
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives